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ABSTRACT : Wound healing at bronchial anastomosis of the lung allograft in 
canine was compared between allografts prescribed with cyclosporine and/or aza-
thioprine and autografts in terms of recanalization of bronchial artery, breaking 
strength and histologic findings. 
1) Restoration of interrupted bronchial artery completed at the 14 day following 
   transplantation in autografts and allografts with cyclosporine, although it has 
   been retarded until day 21 when azathioparine was given. 
2) Satisfactory breaking strength at anastomosis was equally measured in auto-
   grafts and allografts with cyclosporine. In allografts with azathioprine, weak-
   ened breaking strength was noticed on day 14 with significant difference (p<0.05). 
3) From the standpoint of histologic finding, cyclosporine is of benefit to eliminate 
   inflammatory response and to promote collagen production which was essential 
   to good wound healing.
       INTRODUCTION 
 For the purpose of advances in organ trans-
plantation, potent immunosuppressive drugs 
and /or procedures are required. Much ad-
vances in new immunosuppressants may contri-
bute to improvement of the results of organ 
transplantations more and more as would be 
expected. 
 Recently it has become evident that cyclo-
sporine A (CsA) is a potent and efficient drug 
to supress the immunoresponse following vari-
ous organ transportations. 
 In the present series, the effect of cyclo-
sporine on supressing immunoresponse to lung
allotransplantation is to clarify in terms of 
bronchial healing at anastomosis. 
    MATERIAL AND METHOD 
 Mongrel dogs, weighing 15 to 20kg were pre-
pared. These dogs were selected at random for 
a pair of donor and recipient in whom body 
weight was matched as far as possible. 
 The donor lung was taken from a donor under 
left thoracotomy and it was transplanted to 
the recipient which was prepared by left thora-
cotomy after removal of the left lung at the 
same time. 
 Left lung transplantation was based on con-
ventional method in which cuff anastomosis of
the left atrial wall was used for anastomosis 
between the pulmonary veins. 
 The dogs eligible to this study were divided 
into three groups. Group 1 (G1) comprised 15 
autotransplantations which was transplanted 
immediately after removal. Group 2 (G2) was 
18 allotransplantations with azathioprine as 
an immunosuppressive drug and Group 3 (G3) 
was 18 allotransplantations with cyclosporine. 
In G2, azathioprine was given at a dosis of 4-5 
mg/kg/day as an immunosuppressive drug. 
Meanwhile in G3, cyclosporine A was used at 
a dosis of 20mg/kg/day. 
 The recanalization of bronchial artery was 
evaluated by the use of microangiogram as al-
ready reported 4) and graded at the 7th, 14th 
and the 21 or 28th day after lung auto- and allo-
transplantations. 
 The tensile strength at bronchial anastomo-
sis was also compared with each group by mea-
surement of breaking-down point against pull-
ing force to a 1cm bronchial strip specimen at 
anastomosis by using DSC 500 (SHIMAZU CO) 
as described 5) on day 7, 14, 21 and and 28 re-
spectively following lung transplantation at 
sacrifice. 
  Furthermore, the process of wound healing 
at bronchial anstomosis was histologically ob-
served. Histologic inflammation was graded 
by inflammatory score as shown in Table 1.
we could assess on microangiogram was indi-
cated in Fig. 1. 
   The degree of the newly growing arteries 
   of the anastmotic site 
   Autograft Group
Table 1. Inflammatory response scorE
1) inflammatory cell type 
    migration of neutrophiles 3 
                neutrophiles, lymphocyte 2
               lymphocyte 1
2) bleeding 1 
3) edema 1 
4) focal degeneration necrosis 1 
5) ulcer 1 
6) proliferation of collagen fiber 
    slight 3 
    moderate 2
    marked 1
         RESULT 
The degree of the arterial recanalization that
 Fig. 1. The degree of recanalization of the 
   bronchial artery at anastomosis on day 7, 
   14 and 21-28 following lung transplantation 
   in each group. 
 In autograft, the arterial recanalization at 
least was starting on day seven and almost 
completed on day 14. 
 In the cyclosporine A-adminstered group(G3), 
the start of the arterial recanalization was 
somewhat delayed but on day 14 it was almost 
completed. On the contrary, in the azathioprine-
administered group (G2), both begining and 
completion of arterial recanalization were ap-
parently retarded. Breaking strength was com-
pared in each group as shown in Fig. 2. In the 
autograf t it was increasing with time but even 
in the allografts that cyclosporine A was given,
Breaking Strength of a 1 cm bronchial strip
Fig. 2. Breaking strength using a 1cm bron-
 chial strip specimen with time after lung 
 transplantation in autografts and allo-
 grafts prescribed azathioprine and cyclo-
 sporine.
it was increased with a similar fashion to that 
of the autograft. On the other hand, in the allo-
grafts with azathioprine as an immunosuppres-
sive drug, bronchial wound healing in terms of 
obtaining breaking strength was mostly im-
paired on day seven with significant difference
(p<0.05). However, it became increased to the 
same as the other groups 21 days later. 
 Histologic finding showed that inflammation 
at anastomosis was almost the same pattern 
between the autograft and the allograft with c 
yclosporine, although the allograft with aza-
thioprine had demostrated pronounced inflam-
matory response as summarized. in Table 2. 
According to cell types, neutrophile and lym-
phocyte migration was remarkable finding. 
Production of collagen fiber was also pro-
nounced in the autograft and the allograft with 
cyclosporine. In contrast, in case that azathio-
prine was used, collagen fiber histologically 
noted was scanty in, spite of exclusion of rejec-
tion response three weeks later following trans-
plantation. 
         DISCUSSION 
 Bronchial anastmosis trouble following lung 
transplantation is a major concern. It is a ma-
jor concern. It is attributable to the direct or
Table 2. Histologic finding at bronchial anastomosis
               after transpl. 1W 2W 3W 
Autograft inflamm. score 9.1 ± 1.5 4.8 ± 1.3 3.0 ± 0 
               neutro 50 7 7 
            %neut-Lym 1 30 1
            Lym 1 70 100
              no cell 50 1 1 
                                      S. mod. mark S. mod. mark S. mod. mark
             collagen 83.4 16.6 1 20 50 30 0 100 1
Allograft inflamm. score 8.8 ± 0.8 7.2 ± 1.6 4.0 ± 1 
  Aza neutro 87.5 87.5 1 
             %neut-Lym 13.5 1 1
             Lym 1 12.5 100
              no cell 1 1 1
                                      S. mod. mark S. mod. mark S. mod. mark
              collagen 37.5 67.5 0 12.5 50 37.5 0 100 0 
Allograft inflamm. score 8.0 ± 0 5.1 ± 1.2 3.2 ± 109 
  CyA neutro 100 
             %neut-Lym 25 
            Lym 25 50 
              no cell 50 50
                                      S. mod. mark S. mod. mark S. mod. mark
             collagen 0 100 0 37.5 37.5 25.0 0 50 50
                 inflamma. score : inflammatory score, S : slight 
                 mod.: moderate, mark : marked, neutro : neutrophile 
               Lym : Lymphocyte
indirect action of immunosuppressive drugs, 
poor blood supply to the anastomotic site, clum-
sy surgical technique and rejection response as 
cited by VEITH6). 
 It was apparently recognized that wound 
healing at bronchial anastomosis in lung allo-
graf is had been impaired as compared with 
that in autografts with respect to development 
of recannalization of the bronchial artery and 
acquirement of tensile strength at anastomosis. 
GOLEBERG reported that cyclosporine causes pro-
motion of wound healing at bronchial anastom-
osis in contrast with azathioprine. In the pre-
sent study, the development of dense bronchial 
recanalization was not delayed by giving cyclo-
spporine and also weakened breaking strength 
at anastomosis was not observed. On the con-
trary, in the group of giving azathioprine, the 
start and completion of development of bron-
chial recanalization delayed until on day 2 1. 
Furthermore, breaking strength at bronchial 
anastomosis in the allograft with azathioprine 
was much less rather than that with cyclo-
sporine during a period of day seven to 21. It 
is a reflection of delayed and impaired wound 
healing induced by azathioprine at bronchial 
anastomosis as reported by GOLEBERG 7).
 Needless to say, good blood perfusion at bron-
chial anastomosis is required for expecting good 
wound healing. At bronchial anastomosis, it is 
noted that regeneration of interrupted bron-
chial artery starts on day 12 and it completes 
on day 14 to 21 following bronchial anastom-
osis 8 ). Meanwhile, PEASON 9) reported that 
bronchial recanalization has been achieved at 
the third or fourth week after canine lung 
transplantation. It follows that interruption 
of the bronchial artery is inevitable with bron-
chial anastomosis and it leads to poor blood 
supply at anastomosis. 
  Until restoring recanalization of the bron-
chial artery, azathioprine used for immuno-
suppression tends to impair the wound healing 
at bronchial anastomosis due partly to a delay 
in regeneration of the bronchial artery. In gene-
ral, it is believed that cyclosporine A promotes 
wound healing in the bronchial anastomotic 
site 5). The reasons are that cyclosporine causes 
activation of the macrophage 10), promotes 
phagocytic activity of the monocyte 11) and in-
creases monocyte population 12). 
 On the other hand, azathioprine impairs 
wound healing process, in particular, it takes 
at least 21 days to approach the normal level. 
 In the lung allograft wound healing was 
much more retarded than that in the autograft. 
 However, use of cyclosporine for the lung 
allograft results in favorable wound healing as 
seen in the autograft although azathioprine ap-
parently prevent it until day 21 following lung 
transplantation. 
  In conclusion, cyclosporine facilitates wound 
healing at bronchial anastomosis enough to 
prevent bronchial complications in the lung allo-
graft as well as in the autograft. It is a main 
cause that outcome of lung allotransplanta-
tion is improving. 
 According to histologic finding, cyclosporine 
is of use to eliminate inflammatory response 
at anastomosis during a period from the sec-
ond to third week after transplantation as com-
pared with azathioprine. At least with respect 
to histologic healing at anastomosis the same 
healing process as the autograft was observed 
in the allograft that cyclosporine was pres-
cribed. 
 NEMLANDER and AHONE\ 13) reported that cyclo-
sporine does not impaire collagen production 
and neovascularity which is essential to good 
wound healing. 
 It is well known that activated macrophage 
and monocyte and in proliferation of fibro-
blast in the wound healing process and cyclo-
sporine plays a key role in making macrophage 
and monocyte active 13). P1z.TsKBR 14) also noted 
that the bronchial anastomotic site had be-
come adematous but never brought about ana-
stomosis insufficiency or peribronchial abscess 
in help of cyclosporine at rejection. 
 In this present study, it was confirmed that 
the use of cyclosporine was effective not only 
to suppress the immunoresponse but also to 
allow satisfactory wound healing at bronchial 
anastomosis. 
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